Arbutus Biopharma (ABUS) PT Lowered to $6 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $5.07 -1.93%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $6.00 (from $7.50) while maintaining a Buy rating.
You May Also Be Interested In
- Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
- Sarana Menara Nusantara Tbk (TOWR:IJ) (SMNUF) PT Lowered to IDR640 at Macquarie
- Donaldson Company (DCI) PT Raised to $95 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
